[1]
P. Subish, M. Mohamed Izham, P. Mishra, and P. Shaker, “Safety alerts on Rosiglitazone”, J Inst Med Nepal, vol. 31, no. 2, pp. 32–33, Aug. 2009, doi: 10.59779/jiomnepal.388.